Inventor profile of:

Martin Szelagiewicz

City:

Basel

Country:

Switzerland

Published Applications:

20

Last publication date:

2022-01-20

Top Assignees for applications by Martin Szelagiewicz

The entities that hold a legal rights for patent applications filed by inventor Szelagiewicz Martin:

Recent patent applications by Szelagiewicz Martin

Martin Szelagiewicz from Basel, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-01-20
US20220016121A1
Human necessities

Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid

#2 | 2021-09-16
US20210283136A1
Human necessities

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl ester

#3 | 2021-09-09
US20210277006A1
Chemistry; metallurgy

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters

#4 | 2021-09-09
US20210275533A1
Human necessities

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester

#5 | 2021-09-02
US20210269444A1
Chemistry; metallurgy

Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester

#6 | 2021-07-22
US20210220366A1
Human necessities

Crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine

#7 | 2021-04-15
US20210107902A1
Chemistry; metallurgy

Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid

#8 | 2020-02-06
US20200039982A1
Chemistry; metallurgy

Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organic bases

#9 | 2020-01-30
US20200030333A1
Human necessities

Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid

#10 | 2018-08-16
US20180230140A1
Chemistry; metallurgy

MULTICOMPONENT CRYSTALS OF DASATINIB WITH MENTHOL OR VANILLIN

#11 | 2016-10-20
US20160303143A1
Human necessities

Solid form of abiraterone acetate

#12 | 2016-06-16
US20160168143A1
Chemistry; metallurgy

Salts of Dasatinib in crystalline form

#13 | 2016-06-16
US20160168142A1
Chemistry; metallurgy

Salts of dasatinib in amorphous form

#14 | 2015-09-03
US20150246901A1
Chemistry; metallurgy

Multicomponent crystalline system comprising nilotinib and selected co-crystal formers

#15 | 2015-06-25
US20150175544A1
Chemistry; metallurgy

Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof

#16 | 2015-05-14
US20150133463A1
Chemistry; metallurgy

Multicomponent crystals comprising dasatinib and selected co-crystal formers

#17 | 2014-07-10
US20140194453A1
Human necessities

Multicomponent crystalline system of rosuvastatin calcium salt and vanillin

#18 | 2014-06-05
US20140155371A1
Chemistry; metallurgy

MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE

#19 | 2014-01-30
US20140031377A1
Human necessities

Multicomponent crystalline system of rosuvastatin calcium salt and vanillin

#20 | 2013-09-12
US20130237553A1
Chemistry; metallurgy

Multicomponent system of rosuvastatin calcium salt and sorbitol

InventorID:

434822 ⎘